Outcome measures in Duchenne muscular dystrophy: sensitivity to change, clinical meaningfulness, and implications for clinical trials

Publisher： John Wiley & Sons Inc

E-ISSN： 1469-8749|60|2|117-117

ISSN： 0012-1622

Source： DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol.60, Iss.2, 2018-02, pp. : 117-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Corticosteroids in Duchenne muscular dystrophy: impact on the motor function measure sensitivity to change and implications for clinical trials

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 60, Iss. 2, 2018-02 ,pp. : 185-191

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel outcome measures for clinical trials in cystic fibrosis

By  

PEDIATRIC PULMONOLOGY, Vol. 50, Iss. 3, 2015-03 ,pp. : 302-315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Scoliosis in Duchenne Muscular Dystrophy

By  

Respiration, Vol. 66, Iss. 5, 1999-09 ,pp. : 463-463

Karger

Access to resources Recommend Favorite

By  

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. 8, 2015-08 ,pp. : 759-764

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcome reliability in non‐Ambulatory Boys/Men with duchenne muscular dystrophy

By  

MUSCLE AND NERVE, Vol. 51, Iss. 4, 2015-04 ,pp. : 522-532

John Wiley & Sons Inc

Access to resources Recommend Favorite